CARGO Therapeutics, Inc. (CRGX)
Aug 19, 2025 - CRGX was delisted (reason: acquired by Concentra Biosciences)
4.470
-0.070 (-1.54%)
Inactive · Last trade price on Aug 18, 2025
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CARGO Therapeutics stock had an average target of $5.33, with a low estimate of $4.00 and a high estimate of $7.00.
Price Target: $5.33 (+19.24%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for CARGO Therapeutics stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.86
from -3.72
EPS Next Year
-2.41
from -2.86
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.56 | -0.66 | |||
| Avg | -2.86 | -2.41 | |||
| Low | -4.31 | -4.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |